Skip to main content

Register to vote Register by 18 June to vote in the General Election on 4 July.

324 results sorted by Most viewed
From Medicines and Healthcare products Regulatory Agency (MHRA)
  • Information about the risks of taking valproate medicines during pregnancy.

  • How to contact MHRA for specific services or enquiries.

  • Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.

  • How to use this new procedure for medicines licensing applications.

  • How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.

  • How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.

  • Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.

  • How to apply for a traditional herbal registration (THR) to market a herbal medicine in the UK.

  • You must get permission to export certain drugs and medicines.

  • Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'

  • Safety leaflet to help you understand the latest information about the effects of pregabalin during pregnancy.

  • Information on when software applications are considered to be a medical device and how they are regulated.

  • Who can supply and or administer specific medicines to patients without a doctor under a PGD and which medicines can be administered.

  • Apply for a promising innovative medicine (PIM) designation or scientific opinion for your medicine from MHRA.

  • The Medicines and Healthcare Regulatory Agency have launched RegulatoryConnect, a service that provides the capability to track applications and view live authorisation details.

  • How to conform with the legal requirements for placing medical devices on the market.

  • UK companies who have their licence to manufacture or wholesale medicines terminated and cancelled.

  • A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.

  • A wholesale dealer in Great Britain may import Qualified Person certified medicines from the European Economic Area if certain checks are made by the ‘Responsible Person (import)’

  • Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.